Octavius Pharma has developed DC granules of Empagliflozin + Metformin for making its plain film-coated tablets. The product has been developed to produce uniform particles that help give better flowability in a way that facilitates tablet compression, maintaining content uniformity. The finished tablets’ specifications and dissolution profile comply as per IH specifications.
| Strength | 5 + 500 mg / 5 + 1000 mg / 12.5 + 500mg / 12.5 + 1000 mg |
| Finished Dosage Form | Tablets |
| Finished Product Compliance | IH |
| API DMF | Under development |
| CTD Dosssier | Available |
Empagliflozin and Metformin are a combination of two medicines. Empagliflozin prevents glucose reabsorption in the kidneys, causing excess sugar to be excreted in urine. Metformin is a biguanide that lowers glucose production in the liver, delays glucose absorption from the intestines, and increases the body’s sensitivity to insulin.
GET IN TOUCH
For inquiries and collaboration opportunities, reach out to us today! Your gateway to innovative healthcare solutions awaits!
"*" indicates required fields